An HIV vaccine candidate developed at the Duke Human Vaccine Institute has demonstrated the ability to trigger low levels of a rare type of neutralising antibodies (bnAbs) in a small group of participants.
Researchers aim to uncover how extreme weather affects long-term HIV care outcomes and implications for addressing climate change impacts and other chronic health conditions.
The National Institutes of Health and Salk Institute researchers have made strides in understanding the molecular mechanisms behind HIV drug resistance mechanisms.
Dr Avinash Hari Narayanan (MBChB), Clinical Lead at London Medical Laboratory, explains that we need stronger efforts worldwide to end HIV transmission and improve the lives of those living with the disease.
An urban gardening program has received $3.4 million to reduce food insecurity in the Dominican Republic – and was also found to greatly improve HIV outcomes.
Experts Dr Michel Gasana & Dr Frank Lule from World Health Organization – Regional Office for Africa, provide an update on the global picture of Tuberculosis.
Peter Bretscher, from the University of Saskatchewan looks at whether mouse models of cutaneous leishmaniasis are pertinent for vaccination against and treatment of AIDS, infectious diseases, and cancer.
The first ever woman cured from HIV underwent a dual stem-cell transplant, which seems to have made her genetically resistant to HIV and put her cancer into remission.
After receiving a cord blood stem cell transplant to treat acute myeloid leukaemia a woman with diagnosed HIV has had no detectable levels of HIV for 14 months
